NIH director: J&J pause will give researchers time to do more study on certain groups

The pause on the Johnson & Johnson Covid-19 vaccine will allow researchers to investigate a potential link to severe blood clotting events, particularly whether certain types of people are more susceptible, National Institutes of Health Director Dr. Francis Collins said Wednesday.

Click Here to read the entire article...